50 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34710826 | Antisense oligonucleotide repress telomerase activity via manipulating alternative splicing or translation. | 2021 Dec 10 | 2 |
2 | 32825005 | Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy. | 2020 Aug 19 | 1 |
3 | 30612734 | Inhibition of telomerase activity by splice-switching oligonucleotides targeting the mRNA of the telomerase catalytic subunit affects proliferation of human CD4+ T lymphocytes. | 2019 Feb 12 | 1 |
4 | 30887243 | A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells. | 2019 May | 1 |
5 | 30892312 | Visualizing the down-regulation of hTERT mRNA expression using gold-nanoflare probes and verifying the correlation with cancer cell apoptosis. | 2019 May 7 | 2 |
6 | 29563163 | Anti-hTERT siRNA-Loaded Nanoparticles Block the Growth of Anaplastic Thyroid Cancer Xenograft. | 2018 Jun | 1 |
7 | 28291810 | MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer. | 2017 | 1 |
8 | 28425985 | The cellular senescence of leukemia-initiating cells from acute lymphoblastic leukemia is postponed by β-Arrestin1 binding with P300-Sp1 to regulate hTERT transcription. | 2017 Apr 20 | 1 |
9 | 28627628 | Phosphorothioate‑modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy. | 2017 Aug | 3 |
10 | 29657298 | A Novel Long Non-Coding RNA in the hTERT Promoter Region Regulates hTERT Expression. | 2017 Dec 29 | 1 |
11 | 26742579 | Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer. | 2016 Jan | 2 |
12 | 27797329 | [Apoptotic endonuclease EndoG regulates alternative splicing of human telomerase catalytic subunit hTERT]. | 2016 Jul | 2 |
13 | 25666290 | Can Carrier-Mediated Delivery System Promote the Development of Antisense Imaging? | 2015 Oct | 1 |
14 | 26332545 | A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis. | 2015 Sep 3 | 1 |
15 | 24307558 | Molecular imaging and pharmacokinetics of (99m) Tc-hTERT antisense oligonucleotide as a potential tumor imaging probe. | 2014 Feb | 3 |
16 | 24610620 | Bioinformatics analysis of Exonic Splicing Enhancers (ESEs) for predicting potential regulatory elements of hTERT mRNA splicing. | 2014 | 2 |
17 | 25187833 | Antisense oligodeoxynucleotide against human telomerase reverse transcriptase inhibits the proliferation of Eca-109 esophageal carcinoma cells. | 2014 Oct | 1 |
18 | 23562158 | Regulation of telomerase alternative splicing: a target for chemotherapy. | 2013 Apr 25 | 1 |
19 | 22848504 | Antisense oligonucleotide against hTERT (Cantide) inhibits tumor growth in an orthotopic primary hepatic lymphoma mouse model. | 2012 | 1 |
20 | 22893708 | Specificity requirements for human telomere protein interaction with telomerase holoenzyme. | 2012 Oct 5 | 1 |
21 | 20347571 | Administration with telomeric DNA telomere-like oligonucleotides induces enhancement of telomerase activity and resistance against oxidative stress in telomere reverse transcriptase gene-transfected human fibroblasts. | 2010 Oct | 1 |
22 | 18837440 | Telomerase-targeting antisense oligonucleotides carried by polycation liposomes enhance the growth inhibition effect on tumor cells. | 2009 May | 1 |
23 | 19623161 | Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates. | 2009 Oct | 1 |
24 | 20137691 | [Effect of human telomerase reverse transcriptase gene antisense oligonucleotide on sensitivity of gemcitabine in pancreatic cancer cell]. | 2009 Sep 15 | 2 |
25 | 21475859 | Antitumor efficacy of human telomerase reverse transcriptase gene antisense oligonucleotide in pancreatic cancer cells. | 2009 May-Jun | 2 |
26 | 18836295 | An investigation of the effects of nanosize delivery system for antisense oligonucleotide on esophageal squamous cancer cells. | 2008 Nov | 1 |
27 | 17438368 | The inhibitory effects of nanosize delivery system for antisense oligonucleotide of hTERT on EC9706 cells. | 2007 Mar | 2 |
28 | 17560709 | A model for triple helix formation on human telomerase reverse transcriptase (hTERT) promoter and stabilization by specific interactions with the water soluble perylene derivative, DAPER. | 2007 Aug | 2 |
29 | 18006621 | Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors. | 2007 Dec | 3 |
30 | 16615118 | Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR. | 2006 Sep 15 | 2 |
31 | 17177836 | Telomerase antisense inhibition for the proliferation of endometrial cancer in vitro and in vivo. | 2006 Nov-Dec | 1 |
32 | 15682468 | Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line. | 2005 Feb 14 | 1 |
33 | 15737568 | Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells. | 2005 Mar | 2 |
34 | 15829059 | Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA. | 2005 Feb | 3 |
35 | 15832424 | Combined effects of Cantide and chemotherapeutic drugs on inhibition of tumor cells' growth in vitro and in vivo. | 2005 Apr 28 | 1 |
36 | 15862164 | [The effect of short hairpin RNA on hTERT expression]. | 2005 May | 1 |
37 | 15890091 | [Inhibiting expression of human telomerase reverse transcriptase promotes degradation of survivin protein]. | 2005 May | 2 |
38 | 15902727 | Effect of vector-expressed shRNAs on hTERT expression. | 2005 May 21 | 1 |
39 | 15916744 | Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model. | 2005 Jun | 1 |
40 | 14717587 | Inhibition of telomerase activity by preventing proper assemblage. | 2004 Jan 20 | 1 |
41 | 14760759 | Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells. | 2004 Feb 1 | 1 |
42 | 15199161 | Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). | 2004 Jul | 2 |
43 | 15257899 | [Detection of human telomerase reverse transcriptase mRNA of cells in pleural fluid by two-step in situ hybridization using digoxin-labeled oligonucleotide probes]. | 2004 Jul | 1 |
44 | 15569435 | [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo]. | 2004 Oct 17 | 1 |
45 | 15665594 | Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity. | 2004 Winter | 1 |
46 | 20641541 | [99mTc]Human telomerase reverse-transcriptase antisense mRNA oligonucleotide | 2004 | 1 |
47 | 12519411 | Demonstration of human telomerase reverse transcriptase (hTERT) in human parathyroid tumours by in situ hybridization with a new oligonucleotide probe. | 2003 Jan | 2 |
48 | 12838868 | [Targeted therapy of human laryngeal squamous cell carcinoma in vitro with telomerase catalytic subunit mRNA]. | 2003 Apr | 1 |
49 | 14563552 | Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. | 2003 Oct 16 | 1 |
50 | 12678728 | How to inhibit telomerase activity for cancer therapy. | 2002 Sep | 1 |